Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in recurrent bladder cancer after first-line chemotherapy (Phase II)
2009-011049-15Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in bladder cancer, sponsored by Institut Bergonié. Primary endpoints: Non-progression at 8 weeks and Progression. Started May 2009; status: completed.
02
Drugs
temsirolimus
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2009-011049-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011049-15.